Literature DB >> 20092447

Standards for clinical trials in male sexual dysfunctions.

Hartmut Porst1, Yoram Vardi, Emre Akkus, Arnold Melman, Nam Cheol Park, Allen D Seftel, Claudio Teloken, Michael Wyllie.   

Abstract

INTRODUCTION: Clinical trials in male sexual dysfunction (MSD) are expanding. Consequently, there is a need for consensus standards in this area. AIM: To develop an evidence-based, state-of-the-art consensus report on standards for clinical trials in MSD.
METHODS: A literature review was performed examining clinical trials in erectile dysfunction (ED), premature ejaculation (PE), delayed/absent ejaculation, libido disorders/loss of desire, hypogonadism, and Peyronie's disease, focusing on publications published in the last 20 years. This manuscript represents the opinions of eight experts from seven countries developed in a consensus process. This document was presented for peer review and debate in a public forum and revisions were made based on recommendations of chairpersons to the International Consultation on Sexual Medicine. MAIN OUTCOME MEASURE: Expert opinion was based on the grading of evidence-based medical literature, widespread internal committee discussion, public presentation, and debate.
RESULTS: According to experience and recent publications in dealing with clinical trials in sexual dysfunction, recommendations have been made for conducting trials in patients with ED, PE, delayed ejaculation, libido disorders, hypogonadism, and Peyronie's disease.
CONCLUSIONS: It is important that future clinical trials are conducted using standards upon which investigators can rely when reading manuscripts or conducting new trials in this field.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20092447     DOI: 10.1111/j.1743-6109.2009.01623.x

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  9 in total

Review 1.  New concepts in the diagnosis and treatment of premature ejaculation.

Authors:  Christopher E Keel; Phillip J Dorsey; William Acker; Wayne J G Hellstrom
Journal:  Curr Urol Rep       Date:  2010-11       Impact factor: 3.092

Review 2.  Gene therapy for erectile dysfunction: what is the future?

Authors:  Arnold Melman; Kelvin Davies
Journal:  Curr Urol Rep       Date:  2010-11       Impact factor: 3.092

Review 3.  [Conservative therapy of erectile dysfunction].

Authors:  M Trottmann; J Marcon; S Pompe; D Strobach; A J Becker; C G Stief
Journal:  Urologe A       Date:  2015-05       Impact factor: 0.639

Review 4.  Extracorporeal shock wave therapy (ESWT) in urology: a systematic review of outcome in Peyronie's disease, erectile dysfunction and chronic pelvic pain.

Authors:  Grzegorz Lukasz Fojecki; Stefan Tiessen; Palle Jörn Sloth Osther
Journal:  World J Urol       Date:  2016-04-23       Impact factor: 4.226

Review 5.  The Race to Replace PDE5i: Recent Advances and Interventions to Treat or Manage Erectile Dysfunction: Evidence from Patent Landscape (2016-2021).

Authors:  Mohammed Monirul Islam; Nimbagal Raghavendra Naveen; Posina Anitha; Prakash S Goudanavar; G S N Koteswara Rao; Santosh Fattepur; Muhammad Muhitur Rahman; Predeepkumar Narayanappa Shiroorkar; Mohammed Habeebuddin; Girish Meravanige; Mallikarjun Telsang; Sreeharsha Nagaraja; Syed Mohammed Basheeruddin Asdaq; M D Khalid Anwer
Journal:  J Clin Med       Date:  2022-05-31       Impact factor: 4.964

6.  Tadalafil for prevention of erectile dysfunction after radiotherapy for prostate cancer: the Radiation Therapy Oncology Group [0831] randomized clinical trial.

Authors:  Thomas M Pisansky; Stephanie L Pugh; Richard E Greenberg; Nadeem Pervez; Daniel R Reed; Seth A Rosenthal; Rex B Mowat; Adam Raben; Mark K Buyyounouski; Lisa A Kachnic; Deborah W Bruner
Journal:  JAMA       Date:  2014-04-02       Impact factor: 56.272

Review 7.  All about Peyronie's disease.

Authors:  Ahmed A Hussein; Amjad Alwaal; Tom F Lue
Journal:  Asian J Urol       Date:  2015-04-16

Review 8.  A mini-review of quality of life as an outcome in prostate cancer trials: patient-centered approaches are needed to propose appropriate treatments on behalf of patients.

Authors:  Yohann Foucher; Marine Lorent; Philippe Tessier; Stéphane Supiot; Véronique Sébille; Etienne Dantan
Journal:  Health Qual Life Outcomes       Date:  2018-03-05       Impact factor: 3.186

9.  On-demand use of tramadol, sildenafil, paroxetine and local anaesthetics for the management of premature ejaculation: A randomised placebo-controlled clinical trial.

Authors:  Tarek A Gameel; Ahmad M Tawfik; Mohamed O Abou-Farha; Mohamed G Bastawisy; Mohamed A El-Bendary; Abd El-Naser El-Gamasy
Journal:  Arab J Urol       Date:  2013-06-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.